Ramy R. Saleh

Holistic Medicine
1502 W Mineral King Ave
Visalia, CA 93291

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 56 publications

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

GPNMB-directed CAR T cell therapy against MiT/TFE-family fusion-driven solid tumors.

Journal: Nature cancer
Published: April 29, 2026

Metastatic Renal Cell Carcinoma with Concomitant Minimal Change Disease: Enabling Immunotherapy with Rituximab - A Case Report.

Metastatic Renal Cell Carcinoma with Concomitant Minimal Change Disease: Enabling Immunotherapy with Rituximab - A Case Report.

Journal: Case reports in oncology
Published: April 07, 2026

Rhabdomyosarcoma Confined to the Bone Marrow: A Case Report and Literature Review.

Rhabdomyosarcoma Confined to the Bone Marrow: A Case Report and Literature Review.

Journal: Current oncology (Toronto, Ont.)
Published: March 24, 2026

Maintenance Liposomal Doxorubicin Following Induction Doxorubicin in Soft Tissue Sarcoma: A Single-Center Observational Study.

Maintenance Liposomal Doxorubicin Following Induction Doxorubicin in Soft Tissue Sarcoma: A Single-Center Observational Study.

Journal: Current oncology (Toronto, Ont.)
Published: March 24, 2026

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

Vimseltinib for patients with tenosynovial giant cell tumor: A multicenter, open-label, phase 2 trial.

Journal: Cancer
Published: December 24, 2025

CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.

CANLead: Canada as a Phase 1 Clinical Trial Leader - Opportunities, Initiatives, and Collaborative Innovation to Elevate National Competitiveness.

Journal: The oncologist
Published: November 24, 2025

A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

A Real-World Analysis of Outcomes in CIC-Rearranged Sarcomas: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) Study.

Journal: Cancer medicine
Published: September 09, 2025

Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) study.

Incidence, prevalence and treatment of patients with Epithelioid Haemangioendothelioma (EHE) in Canada: A Canadian Sarcoma Research and Clinical Collaboration (CanSaRCC) and Multi-pronged Canadian Research in Epithelioid Haemangioendothelioma (PRO_CARE EHE) study.

Journal: European journal of cancer (Oxford, England : 1990)
Published: August 27, 2025

Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial.

Pimicotinib versus placebo for tenosynovial giant cell tumour (MANEUVER): an international, randomised, placebo-controlled, phase 3 trial.

Journal: Lancet (London, England)
Published: August 18, 2025

Evaluating the Role of Liquid Biopsy to Detect Pathogenic Homologous Recombination Repair (HRR) Gene Alterations in Metastatic Prostate Cancer.

Evaluating the Role of Liquid Biopsy to Detect Pathogenic Homologous Recombination Repair (HRR) Gene Alterations in Metastatic Prostate Cancer.

Journal: Cancers
Published: August 17, 2025

Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.

Real-world assessment of clinical outcomes of first-line treatment in metastatic papillary renal cell carcinoma.

Journal: The oncologist
Published: May 23, 2025

KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.

KRAS ctDNA Detection in Patients With Resectable Lung Adenocarcinoma.

Journal: Clinical lung cancer
Published: January 08, 2025
Showing 1-12 of 56

Last Updated: 09/26/2026